For example, while we observed increased AD pathology upon KD of EP300/CBP in the form of Aβ42 secretion (Fig. 6E), it is possible that the exclusively neuronal makeup of our model prevented us from observing potential beneficial effects of EP300/CBP KD. The gene discussed is EP300; the disease is Alzheimer disease.